Value-based medicine and interventions for macular degeneration.
about
Role of pegaptanib sodium in the treatment of neovascular age-related macular degenerationAnti-VEGF agents for age-related macular degeneration.Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration.The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.Treatment of age-related macular degeneration: focus on ranibizumabDirect Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure.
P2860
Value-based medicine and interventions for macular degeneration.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Value-based medicine and interventions for macular degeneration.
@ast
Value-based medicine and interventions for macular degeneration.
@en
type
label
Value-based medicine and interventions for macular degeneration.
@ast
Value-based medicine and interventions for macular degeneration.
@en
prefLabel
Value-based medicine and interventions for macular degeneration.
@ast
Value-based medicine and interventions for macular degeneration.
@en
P2093
P1476
Value-based medicine and interventions for macular degeneration.
@en
P2093
Gary C Brown
Heidi Brown
Melissa M Brown
P304
P356
10.1097/ICU.0B013E3281377209
P577
2007-05-01T00:00:00Z